Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection causing
coronavirus disease 2019 (COVID‐19) is the biggest pandemic of our lifetime to date. No …

As the world navigates the coronavirus disease 2019 (COVID-19) pandemic, there is a
growing need to assess its impact in patients with autoimmune rheumatic diseases, such as …

With the outbreak and rapid spread of COVID-19, the world health situation is
unprecedentedly severe. Systemic lupus erythematosus (SLE) is a common autoimmune …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading rapidly across
the world, posing a major health concern with the coronavirus disease 2019 (COVID-19) …

The global spread of coronavirus disease-19 (COVID-19) caused by severe acute
respiratory syndrome coronavirus-2, which originated from Wuhan, China, is likely to have …

At the end of 2019, a new enemy appeared on the world scene in the shape of the new
coronavirus SARS-CoV-2 or 2019-nCoV, thus leading to the third major coronavirus …

The SARS-CoV-2 novel coronavirus has caused the COVID-19 pandemic with over 35
million cases and over a million deaths worldwide as of early October 2020. The populations …

The ongoing pandemic coronavirus disease 19 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a matter of global concern …

Background: It has been over a year since the first documented case of the COVID-19 virus
was recorded. Since then, our understanding of this virus has continually evolved, however …

Abstract The coronavirus disease-2019 (COVID-19) pandemic is likely to pose new
challenges to the rheumatology community in the near and distant future. Some of the …